Menu

MedPAC Finishes Term Voting on Recommendations for Congress Related to Part B Drug Spending, Post-Acute Care Payment System

On April 6-7, 2017, the Medicare Payment Advisory Commission (MedPAC) held their final public meeting of this term. The Commissioners finished out this term by voting on draft recommendations presented at previous meetings and discussing a wide range of topics, including Medicare Part B drug payment, a unified payment system for post-acute care, and payment […]

Read More

CBO Estimates Bill Blocking the Part B Drug Demo Will Cost $395 Million

Today, the Congressional Budget Office (CBO) released an estimate of the savings that could potentially be realized if CMS were to implement the proposed payment reductions and value-based purchasing tools for physician-administered drugs covered under Medicare Part B. The estimate was made within the context of H.R. 5122, “A bill to prohibit further action on the […]

Read More